pifithrin has been researched along with apigenin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, S; Shukla, S | 1 |
| Chen, M; Eibl, G; Go, VL; Hines, OJ; King, JC; Li, G; Lu, QY; Moro, A; Reber, HA; Takahashi, H | 1 |
| Chen, SL; Chou, MY; Chou, SS; Liao, PH; Pan, YF; Yang, SH | 1 |
3 other study(ies) available for pifithrin and apigenin
| Article | Year |
|---|---|
Apigenin-induced prostate cancer cell death is initiated by reactive oxygen species and p53 activation.
Topics: Acetylcysteine; Antineoplastic Agents, Phytogenic; Antioxidants; Apigenin; Apoptosis; Benzothiazoles; Cell Death; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Humans; Male; Membrane Potential, Mitochondrial; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-mdm2; Reactive Oxygen Species; Signal Transduction; Toluene; Transcription Factor RelA; Tumor Suppressor Protein p14ARF; Tumor Suppressor Protein p53 | 2008 |
Evidence for activation of mutated p53 by apigenin in human pancreatic cancer.
Topics: Animals; Apigenin; Apoptosis; Apoptosis Regulatory Proteins; bcl-X Protein; Benzothiazoles; Cell Line, Tumor; Dietary Supplements; Humans; Male; Mice; Mice, Nude; Mutation; Neoplasms, Experimental; Pancreatic Neoplasms; Proto-Oncogene Proteins; Toluene; Tumor Suppressor Protein p53 | 2012 |
The novel p53-dependent metastatic and apoptotic pathway induced by vitexin in human oral cancer OC2 cells.
Topics: Antineoplastic Agents, Phytogenic; Apigenin; Apoptosis; bcl-2-Associated X Protein; Benzothiazoles; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Flavonoids; Humans; Matrix Metalloproteinase 2; Mouth Neoplasms; Plasminogen Activator Inhibitor 1; PPAR gamma; Signal Transduction; Toluene; Tumor Suppressor Protein p53; Up-Regulation | 2013 |